(Q67934396)
Statements
Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites (English)
L J Old
H F Oettgen
S Vadhan-Raj
E Carswell
D Mintzer
L Dantis
C Duteau
M A Templeton
A N Houghton
1 October 1988